RAD
Price sensitive
RAD202 Phase 1 HEAT Trial Advances to Dose Level 3
Radiopharm Theranostics Ltd
No summary is available for this announcement — open the PDF to read it in full.
Sign in for more about this company, including guidance changes and other insights.
Sign in